Kyowa Kirin Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis

Go back to Kyowa Kirin Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis
Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) Delayed: 19.70 +0.32 (1.65%)
Previous Close $19.38    52 Week High $18.64 
Open $19.45    52 Week Low $12.59 
Day High $19.73    P/E N/A 
Day Low $19.08    EPS $0.00 
Volume 34,101